These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19277871)

  • 1. Modeling subpopulations with the $MIXTURE subroutine in NONMEM: finding the individual probability of belonging to a subpopulation for the use in model analysis and improved decision making.
    Carlsson KC; Savić RM; Hooker AC; Karlsson MO
    AAPS J; 2009 Mar; 11(1):148-54. PubMed ID: 19277871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of mixture modeling with count data using NONMEM.
    Frame B; Miller R; Lalonde RL
    J Pharmacokinet Pharmacodyn; 2003 Jun; 30(3):167-83. PubMed ID: 14571690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of visual predictive checks accounting for multimodal parameter distributions in mixture models.
    Arshad U; Chasseloup E; Nordgren R; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2019 Jun; 46(3):241-250. PubMed ID: 30968312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of overdispersed count data by mixtures of Poisson variables and Poisson processes.
    Hougaard P; Lee ML; Whitmore GA
    Biometrics; 1997 Dec; 53(4):1225-38. PubMed ID: 9423246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance in population models for count data, part I: maximum likelihood approximations.
    Plan EL; Maloney A; Trocóniz IF; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2009 Aug; 36(4):353-66. PubMed ID: 19653080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two bootstrapping routines for obtaining imprecision estimates for nonparametric parameter distributions in nonlinear mixed effects models.
    Baverel PG; Savic RM; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):63-82. PubMed ID: 21076858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the nonparametric estimation method in NONMEM VI.
    Savic RM; Kjellsson MC; Karlsson MO
    Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy.
    Vera-Llonch M; Brandenburg NA; Oster G
    Epilepsia; 2008 Mar; 49(3):431-7. PubMed ID: 17822431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixture models and subpopulation classification: a pharmacokinetic simulation study and application to metoprolol CYP2D6 phenotype.
    Kaila N; Straka RJ; Brundage RC
    J Pharmacokinet Pharmacodyn; 2007 Apr; 34(2):141-56. PubMed ID: 17053980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothesis testing in semiparametric additive mixed models.
    Zhang D; Lin X
    Biostatistics; 2003 Jan; 4(1):57-74. PubMed ID: 12925330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Working covariance model selection for generalized estimating equations.
    Carey VJ; Wang YG
    Stat Med; 2011 Nov; 30(26):3117-24. PubMed ID: 21748775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lasso--a novel method for predictive covariate model building in nonlinear mixed effects models.
    Ribbing J; Nyberg J; Caster O; Jonsson EN
    J Pharmacokinet Pharmacodyn; 2007 Aug; 34(4):485-517. PubMed ID: 17516152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures.
    Miller R; Frame B; Corrigan B; Burger P; Bockbrader H; Garofalo E; Lalonde R
    Clin Pharmacol Ther; 2003 Jun; 73(6):491-505. PubMed ID: 12811359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM.
    Langdon G; Gueorguieva I; Aarons L; Karlsson M
    Eur J Clin Pharmacol; 2007 May; 63(5):485-98. PubMed ID: 17345074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling longitudinal daily seizure frequency data from pregabalin add-on treatment.
    Ahn JE; Plan EL; Karlsson MO; Miller R
    J Clin Pharmacol; 2012 Jun; 52(6):880-92. PubMed ID: 21646441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixture modeling for the detection of subpopulations in a pharmacokinetic/pharmacodynamic analysis.
    Lemenuel-Diot A; Laveille C; Frey N; Jochemsen R; Mallet A
    J Pharmacokinet Pharmacodyn; 2007 Apr; 34(2):157-81. PubMed ID: 17151938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unit-treatment interaction and its practical consequences.
    Gadbury GL; Iyer HK
    Biometrics; 2000 Sep; 56(3):882-5. PubMed ID: 10985231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population pharmacokinetic model of gabapentin developed in nonparametric adaptive grid and nonlinear mixed effects modeling.
    Carlsson KC; van de Schootbrugge M; Eriksen HO; Moberg ER; Karlsson MO; Hoem NO
    Ther Drug Monit; 2009 Feb; 31(1):86-94. PubMed ID: 19077930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.